Pietro Iaffaldano

Associate Professor of Neurology

University of Bari Aldo Moro

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Pietro Iaffaldano is an Associate Professor of Neurology at the University of Bari Aldo Moro in Italy. His research focuses on multiple sclerosis, with recent articles examining treatment effectiveness, disability progression, and the implications of various therapies. He has contributed significantly to the understanding of both clinical and immunological aspects of the disease, including the effects of environmental factors on its progression.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Eleonora Cocco

Associate Professor

University of Cagliari

ITALY

View details

Maria Trojano

University of Bari Aldo Moro

ITALY

View details

Giovanna De Luca

Multiple Sclerosis Centre Medical Coordinator (responsabile Centro SM con incarico di medio alta professionalità)

Ospedale San Raffaele

ITALY

View details

Valentina Simonetti

associate professor

University of Chieti-Pescara

ITALY

View details

Melinda Magyari

Associate professor

University of Copenhagen

DENMARK

View details

Carlo Santoro

University of Bari Aldo Moro

ITALY

View details

Luigi Lavorgna

Università degli Studi della Campania Luigi Vanvitelli

ITALY

View details

francesco patti

Professore Associato di Neurologia SSD Med 26

University of Catania

ITALY

View details

Guy Laureys

Ghent University Hospital

BELGIUM

View details

Alessio Signori

Assistant Professor in Medical Statistics

University of Genoa

ITALY

View details

Silvia Romano

Università degli Studi di Roma La Sapienza

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pietro Iaffaldano

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Early Intensive Versus Escalation Approach: Ten‐Year Impact on Disability in Relapsing Multiple Sclerosis

Long-Term Evaluation of Effectiveness and Immunological Implications of Ocrelizumab in a Real-World Cohort

Eculizumab treatment during pregnancy in a patient with AQP4-IgG-seropositive NMOSD: A case report

Assessment of Vaccine Literacy in People Affected by Multiple Sclerosis: A Cross-Sectional Study From Italy

A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis

Siponimod from fingolimod direct switch in patients transitioning in secondary progressive multiple sclerosis: A single center case series

Maternal smoking and multiple sclerosis risk in offspring: A further clue of prenatal environmental triggers

Influence of Physicians’ Risk Perception on Switching Treatments Between High- Efficacy and Non–high-Efficacy Disease‑modifying Therapies in Multiple Sclerosis

Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network

Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register

Interdisciplinary approach to opportunistic infections: staphylococcal meningitis in a patient with multiple sclerosis on treatment with dimethyl fumarate

Predictors of unemployment status in people with relapsing multiple sclerosis: a single center experience

Risk of Getting COVID-19 in People With Multiple Sclerosis

Correction to: Disability assessment using Google Maps (Neurological Sciences, (2022), 43, 2, (1007-1014), 10.1007/s10072-021-05389-7)

Disability assessment using Google Maps

Neuromyelitis optica spectrum disorders associated with systemic sclerosis: a case report and literature review

PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study

Collaborators (11)

Eleonora Cocco

Maria Trojano

Giovanna De Luca

Valentina Simonetti

Melinda Magyari

Carlo Santoro

Luigi Lavorgna

francesco patti

Guy Laureys

Alessio Signori

Silvia Romano

Make your next move.